GGrantIndex
Sort

40,608 grants matching prostate cancer

Chemical Probes for Metabolic Pathway Discovery in Human Disease

$475,796
Benjamin F Cravatt · Scripps Research Institute, The · R01 · FY2017 · CA

A Combination Therapy to Treat Cancer-Related Fatigue

$475,796
Sriram Yennu · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA

Reducing prostate cancer mortality in African American men by early disease detection using DNA fragmentation profiles and methylated DNA patterns of plasma derived cell free DNA

$475,759
Zoltan Szallasi · Boston Children'S Hospital · R21 · FY2024 · CA

Androgen Metabolism in the PCPT

$475,707
Scott M Lippman · University Of Tx Md Anderson Can Ctr · P01 · FY2008 · CA

Molecularly-Targeted Ultrasound in Ovarian Cancer

$475,610
Amelie Lutz · Stanford University · R01 · FY2020 · CA

Tissue/Informatics

$475,583
Lakshmi Priya Kunju · University Of Michigan At Ann Arbor · P50 · FY2018 · CA

Personal Patient Profile-Prostate (P4) Randomized, Multi-site Trial

$475,566
Donna L. Berry · University Of Washington · R01 · FY2006 · NR

Cancer Vaccines and Modulation of Checkpoint Controls in Immunization

$475,552
John Janik · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

Photodestruction of Ovarian Cancer: ErbB3 Targeted Aptamer Nanoparticle Conjugate

$475,527
Tayyaba Hasan · Massachusetts General Hospital · R01 · FY2008 · CA

Project 2: Reversing resistance caused by lineage plasticity through epigenetic therapy

$475,484
Yu Chen · Sloan-Kettering Inst Can Research · U54 · FY2021 · CA

Project 1: Molecular Predictors of Prostate Cancer Progression and Mortality

$475,269
Heather Cheng · Fred Hutchinson Cancer Center · P50 · FY2024 · CA

Addressing Urban Rural Disparities in Cancer: The Case for Registry Expansion

$475,193
Cathy J. Bradley · University Of Colorado Denver · R01 · FY2020 · CA

Targeting Castration Resistant Prostate Cancer via Potent Inhibition of Signaling Lipids

$475,058
Salma Kaochar · Baylor College Of Medicine · R01 · FY2023 · CA

Molecular and Genetic Determinants of Invasion in HNSCC

$474,881
Cun-Yu Wang · University Of California Los Angeles · R01 · FY2010 · DE

DEVELOPMENTAL FUNDS

$474,877
Paul A Bunn · University Of Colorado Denver · P30 · FY2015 · CA

Role of BMP and FGF signaling during limb development

$474,836
Mark B Lewandoski · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

EXPLOITING THE IMMUNE MICROENVIRONMENT VARIATION IN SUBTYPES OF METASTATIC PROSTATE CANCER

$474,771
Fred Hutchinson Cancer Research Center · · FY2021 · Defense Health Agency

Imaging Feedback to Guide Ultrasonic Tissue Fractionation for Cancer Therapy

$474,760
Charles Alan Cain · University Of Michigan At Ann Arbor · R01 · FY2010 · CA

Software for Meta-Analysis of Diagnostic Tests

$474,666
Michael Borenstein · Biostatistical Programming Assoc, Inc. · R44 · FY2008 · AG

Molecular Determinants of Response and Resistance to EZH2 and PARP inhibition in Prostate Cancer

$474,523
Himisha Beltran · Dana-Farber Cancer Inst · P50 · FY2023 · CA

The Early Detection Research Network: Biomarker Referen*

$474,500
David S Chia · University Of California Los Angeles · U24 · FY2007 · CA

Geisinger Clinical Oncology Program

$474,493
Geisinger Medical Center · U10 · FY2004 · CA

Targeting Autophagy in Hereditary Breast Cancer

$474,468
Bing Xia · Rbhs -Cancer Institute Of New Jersey · R01 · FY2016 · CA

Targeting Autophagy in Hereditary Breast Cancer

$474,468
Bing Xia · Rbhs -Cancer Institute Of New Jersey · R01 · FY2017 · CA

Oncogenic Met Signaling in Urologic Malignancies

$474,446
Donald Bottaro · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA